Skip to content

Stock-Based Comp at other companies

IAR
Integra LifeSciencesIART
$5.17M+176%
MiMedx Group logo
MiMedx GroupMDXG
-$1.7M-140%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$3.64M+8.0%
Solventum logo
SolventumSOLV
$51M+4.1%
The Beauty Health Company logo
The Beauty Health CompanySKIN
$2.08M-40.2%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$2.22M+16.2%

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s stock-based comp?
SANUWAVE Health, Inc. (SNWV) reported stock-based comp of $1.61M in Q1 2026.
How has SANUWAVE Health, Inc.'s stock-based comp changed year-over-year?
SANUWAVE Health, Inc.'s stock-based comp increased by 65.2% year-over-year, from $975K to $1.61M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.